ADAP — ADAPTIMMUNE THERAPUTICS PLC Spon ADS Each Rep 6 Ord Shs

Ownership history in Rathbones Group PLC  ·  41 quarters on record

This page tracks every 13F SEC filing in which Rathbones Group PLC reported a position in ADAPTIMMUNE THERAPUTICS PLC Spon ADS Each Rep 6 Ord Shs (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.2% (2016 Q2)
Avg. % of fund
0.04%
First filed
2015 Q4
Last filed
2025 Q4
Quarters held
41
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 432,818 — 0% 0.00% $11K —
2025 Q3 UNCHANGED 432,818 — 0% 0.00% $56K —
2025 Q2 UNCHANGED 432,818 — 0% 0.00% $104K —
2025 Q1 UNCHANGED 432,818 — 0% 0.00% $85K —
37 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding ADAP

As of 2025 Q4 — sorted by position size

JOSH ARNOLD INVESTMENT CONSULTANT, LLC 3Y 0.03% Empirical Finance, LLC 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0% SIMPLEX TRADING, LLC 3Y 7Y 0.0% RHUMBLINE ADVISERS 3Y 7Y 0.0% BARCLAYS PLC 3Y 7Y 0.0%
← Back to Rathbones Group PLC Holdings